Stuttgart - Delayed Quote EUR
AC Immune SA (IMR.SG)
1.3560
+0.0800
+(6.27%)
At close: 9:30:33 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
27,309
27,309
14,801
3,935
--
Operating Expense
79,687
79,687
68,425
74,782
79,010
Operating Income
-52,378
-52,378
-53,624
-70,847
-79,010
Net Non Operating Interest Income Expense
3,063
3,063
868
-286
5,904
Other Income Expense
-1,598
-1,598
-1,467
393
113
Pretax Income
-50,913
-50,913
-54,223
-70,740
-72,993
Tax Provision
3
3
10
13
3
Net Income Common Stockholders
-50,916
-50,916
-54,233
-70,753
-72,996
Diluted NI Available to Com Stockholders
-50,916
-50,916
-54,233
-70,753
-72,996
Basic EPS
-0.40
-0.51
-0.64
-0.85
-0.97
Diluted EPS
-0.40
-0.51
-0.64
-0.85
-0.97
Basic Average Shares
96,380.1900
99,691.9710
84,694.6160
83,554.4120
74,951.8330
Diluted Average Shares
96,380.1900
99,691.9710
84,694.6160
83,554.4120
74,951.8330
Total Operating Income as Reported
-52,378
-52,378
-53,624
-70,847
-79,010
Total Expenses
79,687
79,687
68,425
74,782
79,010
Net Income from Continuing & Discontinued Operation
-50,916
-50,916
-54,233
-70,753
-72,996
Normalized Income
-49,453.8300
-49,453.8300
-52,890.6950
-71,094.9100
-73,105.6100
Interest Income
3,196
3,196
1,044
69
6,485
Interest Expense
133
133
176
355
581
Net Interest Income
3,063
3,063
868
-286
5,904
EBIT
-50,780
-50,780
-54,047
-70,385
-72,412
EBITDA
-48,618
-48,618
-51,832
-68,026
-70,006
Reconciled Depreciation
2,162
2,162
2,215
2,359
2,406
Net Income from Continuing Operation Net Minority Interest
-50,916
-50,916
-54,233
-70,753
-72,996
Total Unusual Items Excluding Goodwill
-1,598
-1,598
-1,467
393
113
Total Unusual Items
-1,598
-1,598
-1,467
393
113
Normalized EBITDA
-47,020
-47,020
-50,365
-68,419
-70,119
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0001
0
Tax Effect of Unusual Items
-135.8300
-135.8300
-124.6950
51.0900
3.3900
12/31/2021 - 8/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
473A.SG Adaptimmune Therapeutics PLC
0.2260
+2.73%
3G0.BE Altimmune Inc
4.4110
+4.03%
2VSA.DU Verastem Inc. R
6.35
+6.72%
PH4.DU CStone Pharmaceuticals
0.3220
+5.92%
F6T.SG Fate Therapeutics Inc
1.1970
+1.57%
MDG1.F Medigene AG
0.2190
+30.36%
TBPH Theravance Biopharma, Inc.
9.45
+1.50%
OCS Oculis Holding AG
17.89
+0.62%
VOR Vor Biopharma Inc.
0.7591
+8.13%
SCPH scPharmaceuticals Inc.
2.6000
-0.38%